Heavy metal and solvent contamination at factories in a major Indian drug manufacturing hub

Report an error

Summary

AI-generated

This summary is written by a language model reading the source document. It is not the publisher's words and is not a substitute for the original.

Learn more about AI enrichment

The report finds that pharmaceutical companies in Hyderabad continue to discharge untreated or inappropriately treated wastewater containing toxic heavy metals and solvents, leading to severe ecological damage and human health risks. It highlights a failure of local and national regulatory bodies to control these emissions and warns that the situation is deteriorating as production capacity expands. The document specifically links antibiotic production discharges to the global spread of antimicrobial resistance (AMR) and argues that pharmaceutical purchasers in the EU and US must address these supply chain failures.

Key insights

AI-generated

These insights are written by a language model reading the source document. They are not the publisher's words and are not a substitute for the original.

Learn more about AI enrichment
  • Pharmaceutical companies in Hyderabad are continuing to discharge untreated or inappropriately treated wastewater, and the situation has not improved or has deteriorated over the two years preceding the report.
  • Pollution from antibiotic production in Hyderabad contributes to the global health threat of antimicrobial resistance (AMR), with evidence showing travelers from India returning to Sweden with drug-resistant bacteria.
  • Indian government regulators are failing to hold the industry accountable, with some evidence suggesting that regulations are becoming more lax through the lifting of plant expansion restrictions and the weakening of the Comprehensive Environmental Pollution Index (CEPI).
  • Severe ecological impacts have been recorded in local water bodies, including mass fish kills in Gandigudem lake (230,000 fish), Edulabad lake (400,000 fish), and Isnapur lake (over 50,000 fish).
  • Groundwater in the Nalgonda district east of Hyderabad contains lead, cadmium, vanadium, and arsenic at levels thousands of times higher than WHO and BIS drinking water standards, partly due to pharmaceutical industry activity.

Cite the original document

APA
Changing Markets Foundation (2018). Heavy metal and solvent contamination at factories in a major Indian drug manufacturing hub. https://changingmarkets.org/wp-content/uploads/2023/10/CM-HYDERABAD-s-PHARMACEUTICAL-POLLUTION-CRISIS-EX-SUMMARY-WEB-SPREAD.pdf
Chicago
Changing Markets Foundation. Heavy metal and solvent contamination at factories in a major Indian drug manufacturing hub. 2018. https://changingmarkets.org/wp-content/uploads/2023/10/CM-HYDERABAD-s-PHARMACEUTICAL-POLLUTION-CRISIS-EX-SUMMARY-WEB-SPREAD.pdf.
Wikipedia
{{cite report |author=Changing Markets Foundation |title=Heavy metal and solvent contamination at factories in a major Indian drug manufacturing hub |date=January 2018 |url=https://changingmarkets.org/wp-content/uploads/2023/10/CM-HYDERABAD-s-PHARMACEUTICAL-POLLUTION-CRISIS-EX-SUMMARY-WEB-SPREAD.pdf |access-date=23 October 2026 |via=Climate Insights Directory}}
BibTeX
@techreport{changingmarketsfoundation2018heavy, author = {{Changing Markets Foundation}}, title = {{Heavy metal and solvent contamination at factories in a major Indian drug manufacturing hub}}, institution = {Changing Markets Foundation}, year = {2018}, month = jan, url = {https://changingmarkets.org/wp-content/uploads/2023/10/CM-HYDERABAD-s-PHARMACEUTICAL-POLLUTION-CRISIS-EX-SUMMARY-WEB-SPREAD.pdf}, urldate = {2026-10-23}, note = {Indexed by Climate Insights Directory} }

Full text

Collected · Record updated